Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moccia

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 13, 2008
Evidences of complex formation between DABA-based nucleo-gamma-peptides with alternate configuration backboneGiovanni Roviello, D Musumeci, M Moccia, et al.
Expert Opinion on Drug Safety|April 21, 2021
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive reviewR Scotto, A Reia, A R Buonomo, et al.
Acta Neurologica Scandinavica|October 8, 2014
Uric acid relates to dopamine transporter availability in Parkinson's diseaseM Moccia, S Pappatà, R Erro, et al.
European Review for Medical and Pharmacological Sciences|January 18, 2024
Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosisM Moccia, L Santoni, I Vaccari, et al.
European Review for Medical and Pharmacological Sciences|March 4, 2024
Author Correction: Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosisM Moccia, L Santoni, I Vaccari, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 30, 2006
Synthesis, characterization and hybridization studies of new nucleo-gamma-peptides based on diaminobutyric acidGiovanni N Roviello, M Moccia, R Sapio, et al.
Multiple Sclerosis and Related Disorders|October 2, 2018
Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosisA Carotenuto, T Costabile, M Moccia, et al.
European Journal of Neurology|August 9, 2014
Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson's diseaseM Moccia, M Picillo, R Erro, et al.
Acta Neurologica Scandinavica|February 4, 2015
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary studyM T Pellecchia, M Picillo, G Santangelo, et al.
European Journal of Neurology|November 2, 2016
Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progressionM Moccia, M Quarantelli, R Lanzillo, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 13, 2008
Evidences of complex formation between DABA-based nucleo-gamma-peptides with alternate configuration backboneGiovanni Roviello, D Musumeci, M Moccia, et al.
Expert Opinion on Drug Safety|April 21, 2021
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive reviewR Scotto, A Reia, A R Buonomo, et al.
Acta Neurologica Scandinavica|October 8, 2014
Uric acid relates to dopamine transporter availability in Parkinson's diseaseM Moccia, S Pappatà, R Erro, et al.
European Review for Medical and Pharmacological Sciences|January 18, 2024
Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosisM Moccia, L Santoni, I Vaccari, et al.
European Review for Medical and Pharmacological Sciences|March 4, 2024
Author Correction: Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosisM Moccia, L Santoni, I Vaccari, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 30, 2006
Synthesis, characterization and hybridization studies of new nucleo-gamma-peptides based on diaminobutyric acidGiovanni N Roviello, M Moccia, R Sapio, et al.
Multiple Sclerosis and Related Disorders|October 2, 2018
Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosisA Carotenuto, T Costabile, M Moccia, et al.
European Journal of Neurology|August 9, 2014
Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson's diseaseM Moccia, M Picillo, R Erro, et al.
Acta Neurologica Scandinavica|February 4, 2015
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary studyM T Pellecchia, M Picillo, G Santangelo, et al.
European Journal of Neurology|November 2, 2016
Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progressionM Moccia, M Quarantelli, R Lanzillo, et al.
Pageof 4